EW vs REX · P/E 47, rev $1.39B vs P/E 15, rev $642.5M
Edwards Lifesciences Corp (EW) versus REX American Resources Corporation (REX) — a side-by-side from cached financials, not a winner call.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
REX American Resources Corporation (REX) is a chemicals company listed on NYSE.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Latest reported REX revenue for 2025-01-31 was $642.5M. Net income was $71.5M. Revenue was down 22.9% from 2024-01-31 to 2025-01-31. REX currently screens at market cap $1.43B and trailing P/E 15.5.
EW currently screens at market cap $49.91B and trailing P/E 46.9. REX currently screens at market cap $1.43B and trailing P/E 15.5.
Not investment advice. Open the EW and REX stock pages for the full models.
Not investment advice.